Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
ClinicalTrials.gov study NCT06339788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Empagliflozin on Ventricular Repolarization.
ClinicalTrials.gov study NCT04117763. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure
ClinicalTrials.gov study NCT05776043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
ClinicalTrials.gov study NCT05879276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
ClinicalTrials.gov study NCT03713190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT04195243. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablet
ClinicalTrials.gov study NCT06823856. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
ClinicalTrials.gov study NCT06889350. IPD Sharing: NO. Countries: 1. Publications: 0.
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
ClinicalTrials.gov study NCT06083675. IPD Sharing: YES. Countries: 13. Publications: 0.
The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .
ClinicalTrials.gov study NCT07247656. IPD Sharing: YES. Countries: 1. Publications: 0.
Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal
ClinicalTrials.gov study NCT06180109. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin and Sympathetic Nerve Traffic
ClinicalTrials.gov study NCT03254849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02637973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
ClinicalTrials.gov study NCT05778084. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in Diuretic Refractory Ascites
ClinicalTrials.gov study NCT05013502. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
ClinicalTrials.gov study NCT05600387. IPD Sharing: NO. Countries: 1. Publications: 0.
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
ClinicalTrials.gov study NCT06715449. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in Hypertrophic Cardiomyopathy
ClinicalTrials.gov study NCT05182658. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
ClinicalTrials.gov study NCT03565458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults
ClinicalTrials.gov study NCT03766724. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.